Annual Drug Patent Expirations for YOSPRALA
Yosprala is a drug marketed by Genus Lifesciences and is included in one NDA. It is available from two suppliers. There are five patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for YOSPRALA.
This drug has forty-four patent family members in twenty-three countries.
The generic ingredient in YOSPRALA is aspirin; omeprazole. Two suppliers are listed for this compound. Additional details are available on the aspirin; omeprazole profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com